Efficacy of Budesonide Combined with Multiple Nutrients in the Prevention of Bronchopulmonary Dysplasia in Premature Infants

Liu Gang; Kuang Ailing; Tan Wei; Huang Lingmin; Zhou Wenting

doi:10.13407/j.cnki.jpp.1672-108X.2021.02.009

您当前的位置：

首页 >

文章列表页 >

Efficacy of Budesonide Combined with Multiple Nutrients in the Prevention of Bronchopulmonary Dysplasia in Premature Infants

更新时间：2022-11-03

- Efficacy of Budesonide Combined with Multiple Nutrients in the Prevention of Bronchopulmonary Dysplasia in Premature Infants
- Vol. 27, Issue 2, Pages: 27-31(2021)
- 作者机构：
  
  湘南学院附属医院,湖南,郴州,423000
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2021.02.009
  CLC：
- Published：2021，
  
  Published Online：10 February 2021，
扫描看全文
Liu Gang, Kuang Ailing, Tan Wei, et al. Efficacy of Budesonide Combined with Multiple Nutrients in the Prevention of Bronchopulmonary Dysplasia in Premature Infants. [J]. 27(2):27-31(2021)
DOI：

Liu Gang, Kuang Ailing, Tan Wei, et al. Efficacy of Budesonide Combined with Multiple Nutrients in the Prevention of Bronchopulmonary Dysplasia in Premature Infants. [J]. 27(2):27-31(2021) DOI： 10.13407/j.cnki.jpp.1672-108X.2021.02.009.

摘要

目的：观察布地奈德联合维生素A为主的多种营养素防治新生儿支气管肺发育不良（BPD）的临床疗效。方法：选取2018年3月至2019年5月新生儿科重症监护室的120例早产儿，采用随机数字分组法分为对照组、布地奈德组和布地奈德+营养素组，对照组接受常规治疗，布地奈德组在常规治疗基础上加用布地奈德雾化吸入治疗，布地奈德+营养素组在常规治疗基础上加用布地奈德联合维生素A为主的多种营养素治疗，记录各组患儿吸氧时间、住院时间及住院期间BPD与其他常见并发症情况，观察治疗前后呼吸机相关参数[吸气峰压（PIP）、呼气末正压（PEEP）、吸入氧浓度（FiO2）、二氧化碳分压（PaCO2）、氧合指数（OI）]及白介素6（IL-6）和肿瘤坏死因子α（TNF-α）的变化。结果：布地奈德组和布地奈德+营养素组吸氧时间和住院时间短于对照组（P<0.05），且布地奈德组上述指标短于布地奈德+营养素组（P<0.05）；治疗后，三组PIP、PEEP、FiO2、IL-6及TNF-α均低于治疗前，OI和PaCO2均高于治疗前（P<0.05），其中布地奈德组和布地奈德+营养素组PIP、PEEP、FiO2、IL-6及TNF-α值均低于对照组，OI和PaCO2高于对照组，且布地奈德组改善程度优于布地奈德+营养素组（P<0.05）；治疗期间，对照组、布地奈德组及布地奈德+营养素组BPD发生率分别为35.00%（14/40）、17.50%和10.00%，其中布地奈德+营养素组BPD发生率明显低于对照组（P<0.05），但三组其他常见并发症发生率比较，差异无统计学意义（P>0.05）。结论：布地奈德联合维生素A为主的多种营养素可有效改善肺通气，降低早产儿BPD的发病率，且安全性较好。

Abstract

Objective: To observe the clinical efficacy of budesonide combined with vitamin A-based multiple nutrients in the prevention and treatment of premature infants with bronchopulmonary dysplasia (BPD). Methods: A total of 120 premature infants in the neonatal intensive care unit from Mar. 2018 to May 2019 were selected to be divided into the control group

the budesonide group and the budesonide + nutrient group via the random number table. The control group received conventional treatment

the budesonide group was treated with budesonide aerosol inhalation on the basis of the conventional treatment

and the budesonide + nutrient group was given budesonide combined with vitamin A-based multiple nutrients on the basis of conventional treatment. The duration of oxygen inhalation

length of stay

BPD and other common complications were recorded. Relevant parameters of the ventilator such as peak inspiratory pressure (PIP)

positive end expiratory pressure (PEEP) and inhaled oxygen concentration (FiO2)

blood gas index such as partial pressure of carbon dioxide (PaCO2)

oxygenation index (OI)

and changes in interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) before and after treatment were observed. Results: The duration of oxygen inhalation and length of stay in the budesonide group and the budesonide + nutrient group were shorter than those in the control group (P<0.05)

and the above indexes in the budesonide + nutrient group were shorter than those in the budesonide group (P<0.05). After treatment

the values of PIP

PEEP

FiO2

IL-6 and TNF-α of three groups were lower than those before treatment

the values of OI and PaCO2 of three groups were higher than those before treatment (P<0.05). The values of PIP

PEEP

FiO2

IL-6 and TNF-α in the budesonide group and the budesonide + nutrient group were lower than those in the control group

and the improvement of OI and PaCO2 were higher than those in the control group

and the improvement in the budesonide + nutrient group was better than that in the budesonide group (P<0.05). During the treatment

the incidences of BPD in the control group

budesonide group and budesonide + nutrient group were respectively 35.00% (14/40)

17.50% and 10.00%

and the incidence of BPD in the budesonide + nutrient group was significantly lower than that in the control group (P<0.05)

yet there was no statistical significance in the incidence of other common complications among three groups (P>0.05). Conclusion: Budesonide combined with vitamin A-based multiple nutrients can effectively improve the lung ventilation and reduce the incidence of BPD in premature infants with higher safety.

关键词

布地奈德维生素A早产儿支气管肺发育不良

Keywords

budesonidetamin Apremature infantsbronchopulmonary dysplasia

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Meta-Analysis of Efficacy and Safety of Different Drug Administration Routes for the Treatment of Premature Infants with Patent Ductus Arteriosus

Effect of Vitamin A Combined with Insulin Detemir-Insulin Aspart Hypoglycemic Regimen on Glycolipid Metabolism and Insulin Resistance in Children with Diabetes

Correlation between Vitamin A, D and E and Severity of Tic Disorder

Systematically Review on Effect of Caffeine at Different Starting Times on Prevention and Treatment of Apnea in Very Low Birth Weight Preterm Infants

A Case of Premature Infant with Cholestasis Induced by Drugs

Related Author

Hua Ziyu

Sun Jian

Shen Yue

Xiang Lingling

Liu Shengyan

Yu Min

Ma Chunlan

Gao Ying

Related Institution

Children’ s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics

Qinghai Women and Children’ s Hospital

Taizhou Hospital of Traditional Chinese Medicine

Huangshi Maternal and Child Health Hospital, Edong Medical Group

Children’s Hospital of Hebei

⁰